Mizuho Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price objective cut by Mizuho from $48.00 to $37.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective indicates a potential upside of 24.75% from the stock’s current price.

Several other analysts also recently commented on the company. Royal Bank of Canada reduced their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, Barclays lowered Acadia Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $43.00 to $35.00 in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $52.19.

Acadia Healthcare Trading Up 3.0 %

Shares of ACHC stock opened at $29.66 on Tuesday. Acadia Healthcare has a fifty-two week low of $27.61 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a 50 day simple moving average of $37.65 and a two-hundred day simple moving average of $45.71. The company has a market cap of $2.76 billion, a P/E ratio of 9.72, a PEG ratio of 1.46 and a beta of 1.38.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently modified their holdings of ACHC. Charles Schwab Investment Management Inc. boosted its position in Acadia Healthcare by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after purchasing an additional 29,936 shares during the last quarter. Cerity Partners LLC boosted its stake in Acadia Healthcare by 43.7% in the third quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock valued at $2,088,000 after acquiring an additional 10,019 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $458,000. Bank of Montreal Can raised its holdings in shares of Acadia Healthcare by 2,456.1% in the 3rd quarter. Bank of Montreal Can now owns 324,569 shares of the company’s stock worth $20,539,000 after purchasing an additional 311,871 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in Acadia Healthcare by 1,601.3% in the third quarter. BNP Paribas Financial Markets now owns 281,220 shares of the company’s stock valued at $17,832,000 after purchasing an additional 264,690 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.